Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TACR1 | P25103 | 1/20 | 0.31 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14324686 | 1.00 | MAPK1 (0.33) | MAPK1HTTALDH1A1GAATACR1 | |
| Hydrochloric Acid SCHEMBL8183614 | 0.99 | ALDH1A1 (0.33) | MAPK1HTTALDH1A1GAATACR1 | |
| SCHEMBL9847303 | 0.87 | SIRT2 (0.31) | SIRT2 | |
| SCHEMBL17610495 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL198654 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL24329940 | 0.83 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL198655 | 0.83 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL7327907 | 0.82 | MMP13 (0.36) | ALDH1A1TACR1 | |
| Water SCHEMBL28484737 | 0.82 | ALDH1A1 (0.33) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28132975 | 0.82 | ALDH1A1 (0.35) | ALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250115557-A1 | TOTAL SYNTHESES OF SELENONEINE, ISO-SELENONEINE, AND ISOMERS | UNIVERSITé LAVAL (CA) | 2025-04-10 | — | — | US | disclosed |
| WO-2023155006-A1 | TOTAL SYNTHESES OF SELENONEINE, ISO-SELENONEINE, AND ISOMERS | UNIVERSITé LAVAL (CA) | 2023-08-24 | — | — | WO | disclosed |
| EP-2371421-A1 | Ligands of insulin degrading enzyme and their uses | Université de Lille 2 Droit et Santé (FR) | 2011-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250115557-A1 | TOTAL SYNTHESES OF SELENONEINE, ISO-SELENONEINE, AND ISOMERS | SCLY, SELENOI, SRM | MAPK1 2923/4885HTT 1203/4885ALDH1A1 2839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.